Dipeptidyl Peptidase-4 Inhibitor Switching as an Alternative Add-on Therapy to Current Strategies Recommended by Guidelines: Analysis of a Retrospective Cohort of Type 2 Diabetic Patients

Dipeptidyl Peptidase 4 ◽

The dipeptidyl peptidase-4 inhibitor alogliptin improves glycemic control in type 2 diabetic patients undergoing hemodialysis

Expert Opinion on Pharmacotherapy ◽

10.1517/14656566.2013.761690 ◽

2013 ◽

Vol 14 (3) ◽

pp. 259-267 ◽

Cited By ~ 30

Author(s):

Yuki Fujii ◽

Masanori Abe ◽

Terumi Higuchi ◽

Mari Mizuno ◽

Hiroko Suzuki ◽

...

Keyword(s):

Glycemic Control ◽

Dipeptidyl Peptidase ◽

Diabetic Patients ◽

Dipeptidyl Peptidase 4 ◽

Hemodynamic effects of the dipeptidyl peptidase-4 inhibitor linagliptin with renin–angiotensin system inhibitors in type 2 diabetic patients with albuminuria

Journal of Hypertension ◽

10.1097/hjh.0000000000002032 ◽

2019 ◽

Vol 37 (6) ◽

pp. 1294-1300 ◽

Cited By ~ 2

Author(s):

Mark E. Cooper ◽

Vlado Perkovic ◽

Per-Henrik Groop ◽

Berthold Hocher ◽

Uwe Hehnke ◽

...

Keyword(s):

Renin Angiotensin System ◽

Dipeptidyl Peptidase ◽

Diabetic Patients ◽

Hemodynamic Effects ◽

Angiotensin System ◽

Dipeptidyl Peptidase 4 ◽

A dipeptidyl peptidase-4 inhibitor, sitagliptin, exerts anti-inflammatory effects in type 2 diabetic patients

Metabolism ◽

10.1016/j.metabol.2012.09.004 ◽

2013 ◽

Vol 62 (3) ◽

pp. 347-351 ◽

Cited By ~ 114

Author(s):

Noriko Satoh-Asahara ◽

Yousuke Sasaki ◽

Hiromichi Wada ◽

Mayu Tochiya ◽

Azusa Iguchi ◽

...

Keyword(s):

Dipeptidyl Peptidase ◽

Diabetic Patients ◽

Dipeptidyl Peptidase 4 ◽

Anti Inflammatory ◽

The dipeptidyl peptidase-4 inhibitor Saxagliptin improves function of circulating pro-angiogenic cells from type 2 diabetic patients

Cardiovascular Diabetology ◽

10.1186/1475-2840-13-92 ◽

2014 ◽

Vol 13 (1) ◽

pp. 92 ◽

Cited By ~ 20

Author(s):

Nicol Poncina ◽

Mattia Albiero ◽

Lisa Menegazzo ◽

Roberta Cappellari ◽

Angelo Avogaro ◽

...

Keyword(s):

Dipeptidyl Peptidase ◽

Diabetic Patients ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase-4 Inhibitor Use Is Not Associated With Acute Pancreatitis in High-Risk Type 2 Diabetic Patients

Medicine ◽

10.1097/md.0000000000002603 ◽

2016 ◽

Vol 95 (7) ◽

pp. e2603 ◽

Cited By ~ 13

Author(s):

Chia-Hsuin Chang ◽

Jou-Wei Lin ◽

Shu-Ting Chen ◽

Mei-Shu Lai ◽

Lee-Ming Chuang ◽

...

Keyword(s):

Acute Pancreatitis ◽

High Risk ◽

Dipeptidyl Peptidase ◽

Diabetic Patients ◽

Dipeptidyl Peptidase 4 ◽

High Risk Type ◽

2.4 Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, Improves the Unfavorable M1/M2- Like Phenotypes of Peripheral Blood Monocytes in Japanese Type 2 Diabetic Patients (377-OR)

Nederlands Tijdschrift voor Diabetologie ◽

10.1007/s12467-013-0038-2 ◽

2013 ◽

Vol 11 (3) ◽

pp. 84-84

Author(s):

Noriko Satoh-Asahara ◽

Shinji Odori ◽

Yousuke Sasaki ◽

Hajime Yamakage ◽

Kazuya Muranaka ◽

...

Keyword(s):

Peripheral Blood ◽

Dipeptidyl Peptidase ◽

Diabetic Patients ◽

Blood Monocytes ◽

Peripheral Blood Monocytes ◽

Dipeptidyl Peptidase 4 ◽

Anagliptin, A Dipeptidyl Peptidase-4 Inhibitor Ameliorates Arterial Stiffness in Association with Reduction of Remnant-Like Particle Cholesterol and Alanine Transaminase Levels in Type 2 Diabetic Patients

Current Vascular Pharmacology ◽

10.2174/1570161114666160625090212 ◽

2016 ◽

Vol 14 (6) ◽

pp. 552-562 ◽

Cited By ~ 10

Author(s):

Nobuhiro Tahara ◽

Sho-ichi Yamagishi ◽

Munehisa Bekki ◽

Norihiro Kodama ◽

Tomohisa Nakamura ◽

...

Keyword(s):

Arterial Stiffness ◽

Dipeptidyl Peptidase ◽

Alanine Transaminase ◽

Diabetic Patients ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase‐4 Inhibitors Attenuate Endothelial Function as Evaluated by Flow‐Mediated Vasodilatation in Type 2 Diabetic Patients

Journal of the American Heart Association ◽

10.1161/jaha.112.003277 ◽

2013 ◽

Vol 2 (1) ◽

Cited By ~ 86

Author(s):

Makoto Ayaori ◽

Naotsugu Iwakami ◽

Harumi Uto‐Kondo ◽

Hiroki Sato ◽

Makoto Sasaki ◽

...

Keyword(s):

Endothelial Function ◽

Dipeptidyl Peptidase ◽

Diabetic Patients ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitors ◽

Plasma Dipeptidyl Peptidase-4 Activity, a Novel Biomarker or Even a Possible Therapeutic Target for Depression in Type 2 Diabetic Patients: Results from a Cross-Sectional Study in China

Psychotherapy and Psychosomatics ◽

10.1159/000455928 ◽

2017 ◽

Vol 86 (4) ◽

pp. 254-256 ◽

Cited By ~ 2

Author(s):

Tianpeng Zheng ◽

Linyuan Qin ◽

Bo Chen ◽

Xueping Hu ◽

Xiaoxi Zhang ◽

...

Keyword(s):

Therapeutic Target ◽

Dipeptidyl Peptidase ◽

Cross Sectional Study ◽

Diabetic Patients ◽

Sectional Study ◽

Cross Sectional ◽

Dipeptidyl Peptidase 4 ◽

The dipeptidyl peptidase-4 (DPP-4) inhibitor vildagliptin improves glycemic control in type 2 diabetic patients undergoing hemodialysis

Endocrine Journal ◽

10.1507/endocrj.ej11-0025 ◽

2011 ◽

Vol 58 (11) ◽

pp. 979-987 ◽

Cited By ~ 54

Author(s):

Midori Ito ◽

Masanori Abe ◽

Kazuyoshi Okada ◽

Hirokazu Sasaki ◽

Noriaki Maruyama ◽

...

Keyword(s):

Glycemic Control ◽

Dipeptidyl Peptidase ◽

Diabetic Patients ◽

Dipeptidyl Peptidase 4 ◽